...eligible for $540 million in milestones per product, plus royalties.Thermo Fisher buying diagnostics company MesaThermo Fisher...
...up front; the deal includes a further $100 million in milestones. The deal gives Thermo Fisher...

...Oncology Review pilot program and Project Orbis.Thermo Fisher grows EU manufacturing presence with €725M dealThermo Fisher...
...in Belgium, for about €725 million ($884 million) in cash. The deal, which gives Thermo Fisher locations...
...terms were not disclosed. BC Staff Viaskin Peanut (DBV-712) Ultomiris, ravulizumab-cwvz (ALXN1210) Darzalex Faspro, DARA-PH20, subcutaneous daratumumab DBV Technologies S.A. Thermo Fisher...

...year with scientific founders Phil Chamberlin, who serves as the company’s president and CSO; Eric Fisher...

...strategy and analytics. Balkin was head of data strategy and data science at Truist Securities.Thermo Fisher...

...“It’s the ultimate conditional gene knockout.” Stew Fisher...
...concept to get different degradation endpoints,”  Stew Fisher...
...with cereblon, and optimize them quickly,” said Fisher...

...highest titers of neutralizing antibodies.Inovio, Thermo Fisher vaccine production dealInovio Pharmaceuticals Inc. (NASDAQ:INO) announced Thermo Fisher...
...which includes Richter-Helm BioLogics GmbH and Ology Bioservices Inc., for 100 million doses in 2021. Thermo Fisher...
...setting this year.TARGETSSPHK2 – Sphingosine kinase 2 BC Staff SpyBiotech Ltd. Serum Institute of India Vaxart Inc. Inovio Pharmaceuticals Inc. Thermo Fisher...

...Among the largest was the $2.1 billion acquisition of viral vector manufacturer Brammer Bio by Thermo Fisher...
...the Advanced Therapy Shipper product line. Amanda Micklus Spark Therapeutics Celgene Corp. Juno Therapeutics Inc. Sorrento Therapeutics Inc. SmartPharm Therapeutics Inc. Thermo Fisher...

...stepped down, a week after shareholders of the molecular diagnostics company rejected an $11.5 billion takeout bid from Thermo Fisher...

...Hanks, the lab uses the TaqPath test kit from Thermo Fisher...

...remain independentQiagen N.V. (NYSE:QGEN; Xetra:QIA) said it terminated its agreement to be acquired by Thermo Fisher...
...shares were tendered by Qiagen shareholders, well below the minimum threshold of 66.7% . Thermo Fisher...
...out the molecular diagnostics company for €39 ($43.33) per share, or about $11.5 billion (see “Thermo Fisher...